126 related articles for article (PubMed ID: 26190286)
1. Antidepressant Treatment with Venlafaxine and Mirtazapine: no Effect on Serum Concentration of Vascular Endothelial Growth Factor (VEGF).
Deuschle M; Gilles M; Scharnholz B; Kahl KG
Pharmacopsychiatry; 2015 Nov; 48(7):292-3. PubMed ID: 26190286
[TBL] [Abstract][Full Text] [Related]
2. Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment.
Deuschle M; Gilles M; Scharnholz B; Lederbogen F; Lang UE; Hellweg R
Pharmacopsychiatry; 2013 Mar; 46(2):54-8. PubMed ID: 22961097
[TBL] [Abstract][Full Text] [Related]
3. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.
Scharnholz B; Weber-Hamann B; Lederbogen F; Schilling C; Gilles M; Onken V; Frankhauser P; Kopf D; Deuschle M
Psychiatry Res; 2010 May; 177(1-2):109-13. PubMed ID: 20381159
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant switching among adherent patients treated for depression.
Marcus SC; Hassan M; Olfson M
Psychiatr Serv; 2009 May; 60(5):617-23. PubMed ID: 19411348
[TBL] [Abstract][Full Text] [Related]
6. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R
Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
[TBL] [Abstract][Full Text] [Related]
7. Venlafaxine in a patient with idiopathic leukopenia and mirtazapine-induced severe neutropenia.
Anghelescu I; Klawe C; Dahmen N
J Clin Psychiatry; 2002 Sep; 63(9):838. PubMed ID: 12363126
[No Abstract] [Full Text] [Related]
8. Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment.
Paslakis G; Luppa P; Gilles M; Kopf D; Hamann-Weber B; Lederbogen F; Deuschle M
J Psychiatr Res; 2010 Jun; 44(8):556-60. PubMed ID: 20022345
[TBL] [Abstract][Full Text] [Related]
9. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
10. S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.
Ambrée O; Bergink V; Grosse L; Alferink J; Drexhage HA; Rothermundt M; Arolt V; Birkenhäger TK
Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv103. PubMed ID: 26364276
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment.
Hellweg R; Ziegenhorn A; Heuser I; Deuschle M
Pharmacopsychiatry; 2008 Mar; 41(2):66-71. PubMed ID: 18311687
[TBL] [Abstract][Full Text] [Related]
12. Possible neurobiological mechanisms underlying faster onset of antidepressant action.
Blier P
J Clin Psychiatry; 2001; 62 Suppl 4():7-11; discussion 37-40. PubMed ID: 11229789
[TBL] [Abstract][Full Text] [Related]
13. An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
Agius M; Gardner J; Liu K; Zaman R
Psychiatr Danub; 2010 Jun; 22(2):346-9. PubMed ID: 20562779
[TBL] [Abstract][Full Text] [Related]
14. Channeling of three newly introduced antidepressants to patients not responding satisfactorily to previous treatment.
Egberts AC; Lenderink AW; de Koning FH; Leufkens HG
J Clin Psychopharmacol; 1997 Jun; 17(3):149-55. PubMed ID: 9169957
[TBL] [Abstract][Full Text] [Related]
15. Neural correlates of treatment outcome in major depression.
Lisiecka D; Meisenzahl E; Scheuerecker J; Schoepf V; Whitty P; Chaney A; Moeller HJ; Wiesmann M; Frodl T
Int J Neuropsychopharmacol; 2011 May; 14(4):521-34. PubMed ID: 21205435
[TBL] [Abstract][Full Text] [Related]
16. Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.
Liappas J; Paparrigopoulos T; Tzavellas E; Rabavilas A
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):55-60. PubMed ID: 15610945
[TBL] [Abstract][Full Text] [Related]
17. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
[TBL] [Abstract][Full Text] [Related]
18. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
[TBL] [Abstract][Full Text] [Related]
20. Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?
Schilling C; Gilles M; Blum WF; Daseking E; Colla M; Weber-Hamann B; Lederbogen F; Krumm B; Heuser I; Wudy SA; Kopf D; Deuschle M
J Clin Psychopharmacol; 2013 Feb; 33(1):99-103. PubMed ID: 23277262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]